ACORN BIOVENTURES, L.P. 13D and 13G filings for Athira Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-08 5:29 pm Purchase | 2026-01-06 | 13G | ATHIRA PHARMA INC ATHA | ACORN BIOVENTURES, L.P. | 596,068 6.200% | 94,329 (+18.80%) | Filing |
| 2025-12-23 4:46 pm Purchase | 2025-12-22 | 13G | ATHIRA PHARMA INC ATHA | ACORN BIOVENTURES, L.P. | 501,739 5.200% | 501,739 (New Position) | Filing |